Frederick Duynslaeger is Senior CMC Writer at Ardena. Trained as an industrial pharmacist, he combines expertise in drug product manufacturing and formulation development with strong technical regulatory writing capabilities.
At Ardena, Frederick specializes in translating complex pharmaceutical development data into clear and high-quality regulatory documentation. Using a dossier-centric approach aligned with global regulatory guidelines, he supports the authoring and review of Module 3 dossiers and related documentation across formulation development, technology transfer, and commercial submission activities. He also contributes to scientific integration across multidisciplinary development teams and supports strategic CMC activities and program management for pharmaceutical development programs.
Frederick brings a combination of pharmaceutical development knowledge and regulatory expertise, supporting efficient and compliant progression of drug development programs toward regulatory milestones.
